The latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...

We remain committed to bringing an ophthalmic bevacizumab to market in the United States and providing retina patients suffering from wet AMD with a much needed treatment option that has the potential ...

Artificial intelligence improves process control and reduces the time required to produce key products such as the COVID-19 ...

AI is transforming how new drugs are discovered, designed and tested. Instead of relying solely on traditional ...

Fapon Biopharma, a biotech innovator in developing therapeutic antibodies and fusion proteins, is pleased to announce that the U.S. Food and Drug ...

NewsMedical speaks with CN Bio about the translatability between in vitro organ-on-a-chip (OOC) models, microphysiological ...

The contents section serves as a navigational ... products approved or submitted for approval under an abbreviated new drug application (ANDA) depends on the labeling of the listed drug referenced ...

In a move aimed at simplifying export procedures and enhancing regulatory efficiency, the Drugs Controller General of India ...

Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental biologics ...

Eli Lilly is lowering the cost barrier to its weight loss drug Zepbound. For many consumers, their insurance denies them ...